| Rank |
Title |
Year |
PubWeight™‹?› |
|
1
|
Standards of medical care in diabetes-2015 abridged for primary care providers.
|
2015
|
1.56
|
|
2
|
Standards of Medical Care in Diabetes-2016 Abridged for Primary Care Providers.
|
2016
|
1.34
|
|
3
|
Diabetes Self-management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics.
|
2016
|
0.89
|
|
4
|
Hemichorea-hemiballism as the first presentation of type 2 diabetes.
|
2015
|
0.89
|
|
5
|
Health Care Disparities and Diabetes Care: Practical Considerations for Primary Care Providers.
|
2009
|
0.89
|
|
6
|
SGLT-2 Inhibitors: A New Mechanism for Glycemic Control.
|
2014
|
0.87
|
|
7
|
Incorrect Insulin Administration: A Problem That Warrants Attention.
|
2016
|
0.83
|
|
8
|
A framework for physician-dentist collaboration in diabetes and periodontitis.
|
2014
|
0.83
|
|
9
|
Older Adults' Perceived Challenges With Health Care Providers Treating Their Type 2 Diabetes and Comorbid Conditions.
|
2014
|
0.81
|
|
10
|
Standards of Medical Care in Diabetes-2017 Abridged for Primary Care Providers.
|
2017
|
0.81
|
|
11
|
First Presentation of Diabetes as Diabetic Ketoacidosis in a Case of Friedreich's Ataxia.
|
2015
|
0.80
|
|
12
|
Stigma in People With Type 1 or Type 2 Diabetes.
|
2017
|
0.80
|
|
13
|
Obesity and Testosterone Levels in Ghanaian Men With Type 2 Diabetes.
|
2014
|
0.80
|
|
14
|
Clinical implications of canagliflozin treatment in patients with type 2 diabetes.
|
2015
|
0.80
|
|
15
|
Screening for Gestational Diabetes Mellitus: Are Guidelines From High-Income Settings Applicable to Poorer Countries?
|
2015
|
0.79
|
|
16
|
Adding GLP-1 Receptor Agonist Therapy to Basal Insulin for Postprandial Glucose Control.
|
2015
|
0.79
|
|
17
|
Diabetes numeracy and blood glucose control: association with type of diabetes and source of care.
|
2014
|
0.79
|
|
18
|
Dietary Sodium Intake in Type 2 Diabetes.
|
2014
|
0.79
|
|
19
|
Play of Chance Versus Concerns Regarding Dipeptidyl Peptidase-4 Inhibitors: Heart Failure and Diabetes.
|
2014
|
0.79
|
|
20
|
Case Series: Retrospective Review of Incidental Retinal Emboli Found on Diabetic Retinopathy Screening: Is There a Benefit to Referral for Work-Up and Possible Management?
|
2008
|
0.79
|
|
21
|
Impact of Performance-Improvement Strategies on the Clinical Care and Outcomes of Patients With Type 2 Diabetes.
|
2014
|
0.79
|
|
22
|
Efficacy and Safety of Canagliflozin as Add-On Therapy to Metformin in Type 2 Diabetes.
|
2014
|
0.79
|
|
23
|
Dynamics, Impact, and Feasibility of Self-Monitoring of Blood Glucose in the Rural, Resource-Constrained Setting of Western Kenya.
|
2015
|
0.78
|
|
24
|
Cutaneous manifestations of diabetes mellitus.
|
2015
|
0.78
|
|
25
|
Disparities in social support systems for youths with type 1 diabetes.
|
2015
|
0.78
|
|
26
|
Clinical Considerations for Insulin Pharmacotherapy in Ambulatory Care, Part One: Introduction and Review of Current Products and Guidelines.
|
2014
|
0.77
|
|
27
|
Therapeutic Options for the Management of Postprandial Glucose in Patients With Type 2 Diabetes on Basal Insulin.
|
2015
|
0.77
|
|
28
|
Disparities in postpartum follow-up in women with gestational diabetes mellitus.
|
2014
|
0.77
|
|
29
|
Legumes: Health Benefits and Culinary Approaches to Increase Intake.
|
2015
|
0.77
|
|
30
|
Successful medical management of severe bilateral emphysematous pyelonephritis: case studies.
|
2015
|
0.77
|
|
31
|
Efficacy and safety of saxagliptin as add-on therapy in type 2 diabetes.
|
2014
|
0.77
|
|
32
|
Evaluating Diabetes Outcomes and Costs Within an Ambulatory Setting: A Strategic Approach Utilizing a Clinical Decision Support System.
|
2014
|
0.77
|
|
33
|
Adherence to Guidelines for Hepatitis B, Pneumococcal, and Influenza Vaccination in Patients With Diabetes.
|
2015
|
0.76
|
|
34
|
Managing Diabetes in Pregnancy Using Cell Phone/Internet Technology.
|
2015
|
0.76
|
|
35
|
Prevalence and determinants of anemia in older people with diabetes attending an outpatient clinic: a cross-sectional audit.
|
2014
|
0.76
|
|
36
|
Evaluating the effect of u-500 insulin therapy on glycemic control in veterans with type 2 diabetes.
|
2015
|
0.76
|
|
37
|
Evaluation of Ward Management of Diabetic Ketoacidosis.
|
2014
|
0.76
|
|
38
|
The diabetes attitudes, wishes and needs second study.
|
2015
|
0.76
|
|
39
|
Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States.
|
2017
|
0.75
|
|
40
|
Self-Reported Gastrointestinal Symptoms in Type 2 Diabetes Improve With an Intensive Lifestyle Intervention: Results From the Action for Health in Diabetes (Look AHEAD) Clinical Trial.
|
2015
|
0.75
|
|
41
|
Patient Activation: A Primary Care Tool to Tackle Overweight and Obesity.
|
2015
|
0.75
|
|
42
|
Racial and Ethnic Disparities in Prevalence and Care of Patients With Type 2 Diabetes.
|
2017
|
0.75
|
|
43
|
Improving the Detection of Foot Abnormalities in Patients With Diabetes.
|
2017
|
0.75
|
|
44
|
Redesigning the Traditional Community Health Screening Model to Provide Blood Glucose Screening and Interdisciplinary Health Education.
|
2015
|
0.75
|
|
45
|
Diabetes Is Devastating, and Insulin Is a Death Sentence: Provider Perspectives of Diabetes Self-Management in Arab-American Patients.
|
2017
|
0.75
|
|
46
|
Respiratory Failure in the Course of Treatment of Diabetic Ketoacidosis.
|
2014
|
0.75
|
|
47
|
Hypoglycemia Prevention in Hospital Patients: A Quality Improvement Project to Prevent Severe and Recurrent Hypoglycemia.
|
2016
|
0.75
|
|
48
|
Pharmacists' Impact on Glycemic Control Among Surgical Patients at a Large Academic Institution.
|
2016
|
0.75
|
|
49
|
Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies.
|
2016
|
0.75
|
|
50
|
A Continuous Subcutaneous Insulin Infusion Needle Break.
|
2015
|
0.75
|